title: SOFT trial can be very hard on young women.
authors.affiliation: Texas Tech University Health Sciences Center, Breast Center of Excellence, 1400 Coulter, 3rd Floor, Amarillo, TX 79106, USA. Electronic address: rakhshanda.rahman@ttuhsc.edu.
authors.forename: Rakhshanda
authors.initials: R
authors.lastname: Layeequr Rahman
authors.affiliation: Department of Obstetrics and Gynecology, Texas Tech University Health Sciences Center, USA.
authors.forename: Teresa
authors.initials: T
authors.lastname: Baker
authors.affiliation: Department of Internal Medicine, Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School, USA.
authors.forename: Sybil
authors.initials: S
authors.lastname: Crawford
authors.affiliation: Department of Obstetrics and Gynecology, Texas Tech University Health Sciences Center, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Kauffman
mesh_terms: D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced / Q000523:psychology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000523:psychology; D005260:Female; D006801:Humans; D010053:Ovary / Q000187:drug effects; D010349:Patient Compliance / Q000523:psychology*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; D013629:Tamoxifen; C508053:ERBB2 protein, human
keywords: Long-term impact; Risks of ovarian suppression; SOFT trial